Literature DB >> 7962048

Association of nuclear matrix antigens with exon-containing splicing complexes.

B J Blencowe1, J A Nickerson, R Issner, S Penman, P A Sharp.   

Abstract

mAbs raised against the human nuclear matrix (anti-NM)1 mAbs have been used to investigate the role of nuclear matrix antigens in pre-mRNA processing. The three anti-NM mAbs used in this study recognize antigens that are highly localized to nuclear matrix speckles. Surprisingly, all three of these mAbs preferentially immunoprecipitate splicing complexes containing exon sequences. The anti-NM mAbs efficiently immunoprecipitate the exon product complex but not complexes containing the lariat product after the second step of splicing. Two of the anti-NM mAbs completely inhibit pre-mRNA splicing in vitro. However, none of the anti-NM mAbs appear to recognize factors stably associated with splicing snRNPs. The three anti-NM mAbs predominantly react with distinct high molecular weight antigens, which belong to a class of nuclear proteins that selectively precipitate with Ser-Arg protein-splicing factors in the presence of high Mg2+ concentrations. Immunological, biochemical, and cell biological data indicate that two of the NM antigens are related to the defined set of Ser-Arg proteins. The results suggest the existence of an extended Ser-Arg family as a component of the nuclear matrix.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962048      PMCID: PMC2120221          DOI: 10.1083/jcb.127.3.593

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  68 in total

1.  Sex-specific splicing and polyadenylation of dsx pre-mRNA requires a sequence that binds specifically to tra-2 protein in vitro.

Authors:  M L Hedley; T Maniatis
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

2.  A mutational analysis of spliceosome assembly: evidence for splice site collaboration during spliceosome formation.

Authors:  A I Lamond; M M Konarska; P A Sharp
Journal:  Genes Dev       Date:  1987-08       Impact factor: 11.361

3.  Nuclear-mitotic apparatus protein: a structural protein interface between the nucleoskeleton and RNA splicing.

Authors:  C Zeng; D He; S M Berget; B R Brinkley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

4.  A splicing enhancer complex controls alternative splicing of doublesex pre-mRNA.

Authors:  M Tian; T Maniatis
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

5.  Higher level organization of individual gene transcription and RNA splicing.

Authors:  Y Xing; C V Johnson; P R Dobner; J B Lawrence
Journal:  Science       Date:  1993-02-26       Impact factor: 47.728

6.  Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators.

Authors:  A R Krainer; A Mayeda; D Kozak; G Binns
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

7.  Core filaments of the nuclear matrix.

Authors:  D C He; J A Nickerson; S Penman
Journal:  J Cell Biol       Date:  1990-03       Impact factor: 10.539

8.  NuMA: an unusually long coiled-coil related protein in the mammalian nucleus.

Authors:  C H Yang; E J Lambie; M Snyder
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

9.  Rat liver nuclear skeleton and ribonucleoprotein complexes containing HnRNA.

Authors:  T E Miller; C Y Huang; A O Pogo
Journal:  J Cell Biol       Date:  1978-03       Impact factor: 10.539

10.  Autonomous splicing and complementation of in vivo-assembled spliceosomes.

Authors:  S Zeitlin; R C Wilson; A Efstratiadis
Journal:  J Cell Biol       Date:  1989-03       Impact factor: 10.539

View more
  81 in total

1.  Reduction of target gene expression by a modified U1 snRNA.

Authors:  S A Beckley; P Liu; M L Stover; S I Gunderson; A C Lichtler; D W Rowe
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Identification and characterization of a novel serine-arginine-rich splicing regulatory protein.

Authors:  D C Barnard; J G Patton
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  Nuclear pre-mRNA compartmentalization: trafficking of released transcripts to splicing factor reservoirs.

Authors:  I Melcák; S Cermanová; K Jirsová; K Koberna; J Malínský; I Raska
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

4.  The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions.

Authors:  H Le Hir; E Izaurralde; L E Maquat; M J Moore
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

5.  The 72/74-kDa polypeptides of the 70-110 S large heterogeneous nuclear ribonucleoprotein complex (LH-nRNP) represent a discrete subset of the hnRNP M protein family.

Authors:  P Kafasla; M Patrinou-Georgoula; A Guialis
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

6.  Seeking common ground in nuclear complexity.

Authors:  L S Shopland; J B Lawrence
Journal:  J Cell Biol       Date:  2000-07-10       Impact factor: 10.539

7.  The protein Mago provides a link between splicing and mRNA localization.

Authors:  H Le Hir; D Gatfield; I C Braun; D Forler; E Izaurralde
Journal:  EMBO Rep       Date:  2001-11-21       Impact factor: 8.807

8.  SRm160 splicing coactivator promotes transcript 3'-end cleavage.

Authors:  Susan McCracken; Mark Lambermon; Benjamin J Blencowe
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

9.  Association of the 72/74-kDa proteins, members of the heterogeneous nuclear ribonucleoprotein M group, with the pre-mRNA at early stages of spliceosome assembly.

Authors:  Panayiota Kafasla; Meropi Patrinou-Georgoula; Joe D Lewis; Apostolia Guialis
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

10.  Inefficient processing impairs release of RNA from the site of transcription.

Authors:  N Custódio; M Carmo-Fonseca; F Geraghty; H S Pereira; F Grosveld; M Antoniou
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.